Intravesical Cabazitaxel, Gemcitabine, and Cisplatin (CGC) in the Treatment Urothelial Carcinoma of the Bladder

PHASE1/PHASE2Active, not recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 1, 2014

Primary Completion Date

April 30, 2026

Study Completion Date

April 30, 2028

Conditions

Urothelial Carcinoma of the Urinary Bladder

Interventions

DRUG

Cabazitaxel

Intravesical instillation of the Cabazitaxel for 2 hours

DRUG

Gemcitabine

Intravesical instillation of Gemcitabine for 2 hours

DRUG

Cisplatin

Intravesical installation of Cisplatin for 2hours

Trial Locations (1)

Columbia University Irving Medical Center - HIP, New York